Mingjun Wu

975 total citations · 1 hit paper
37 papers, 752 citations indexed

About

Mingjun Wu is a scholar working on Molecular Biology, Biotechnology and Immunology. According to data from OpenAlex, Mingjun Wu has authored 37 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 4 papers in Biotechnology and 4 papers in Immunology. Recurrent topics in Mingjun Wu's work include Epigenetics and DNA Methylation (5 papers), Glycosylation and Glycoproteins Research (3 papers) and Extracellular vesicles in disease (3 papers). Mingjun Wu is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Glycosylation and Glycoproteins Research (3 papers) and Extracellular vesicles in disease (3 papers). Mingjun Wu collaborates with scholars based in China, United States and Macao. Mingjun Wu's co-authors include Jingqing Zhang, Dezhang Zhao, Dan He, Qunyou Tan, Chao Yu, Ao Li, Xiaoxun Zhang, Zhu Yang, Xueliang Chen and Hong Wang and has published in prestigious journals such as Advanced Materials, PLoS ONE and Nature Nanotechnology.

In The Last Decade

Mingjun Wu

35 papers receiving 737 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multimodal smart systems reprogramme macrophages and remove urate to treat gouty arthritis

2024 49 citations Mingjun Wu, Dan He et al. Nature Nanotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mingjun Wu China	15	385	92	86	84	75	37	752
Meifang Liu China	18	370 1.0×	176 1.9×	83 1.0×	78 0.9×	64 0.9×	49	1.0k
Lili Huang China	15	385 1.0×	99 1.1×	88 1.0×	129 1.5×	54 0.7×	33	817
Yujun Wang China	16	329 0.9×	107 1.2×	121 1.4×	86 1.0×	111 1.5×	37	1.2k
Yub Raj Neupane Singapore	20	520 1.4×	62 0.7×	138 1.6×	113 1.3×	60 0.8×	42	1.2k
Xiaojun Shi China	16	297 0.8×	66 0.7×	118 1.4×	74 0.9×	47 0.6×	40	947
Chengcheng Song China	18	418 1.1×	61 0.7×	96 1.1×	44 0.5×	74 1.0×	42	778
Chenxi Yang China	16	308 0.8×	70 0.8×	116 1.3×	60 0.7×	48 0.6×	45	763
Ana Carolina Santos de Souza Brazil	16	302 0.8×	76 0.8×	166 1.9×	66 0.8×	47 0.6×	26	741
Felisa Cilurzo Italy	21	496 1.3×	79 0.9×	216 2.5×	96 1.1×	83 1.1×	35	1.3k
Haining Tan China	17	360 0.9×	53 0.6×	117 1.4×	70 0.8×	51 0.7×	51	888

Countries citing papers authored by Mingjun Wu

Since Specialization

Citations

This map shows the geographic impact of Mingjun Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjun Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjun Wu more than expected).

Fields of papers citing papers by Mingjun Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingjun Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjun Wu. The network helps show where Mingjun Wu may publish in the future.

Co-authorship network of co-authors of Mingjun Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Mingjun Wu. A scholar is included among the top collaborators of Mingjun Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingjun Wu. Mingjun Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Mingjun, et al.. (2025). Pathogenesis and clinical management of chronic multilobar segmental bronchial stenosis: a literature review. European journal of medical research. 30(1). 1031–1031.

Li, Yang, Le Xin, Fengsheng Dai, et al.. (2024). The novel DNA methylation marker FIBIN suppresses non-small cell lung cancer metastasis by negatively regulating ANXA2. Cellular Signalling. 120. 111197–111197. 2 indexed citations

Chen, Hongjie, Yucong Chen, Jia Li, et al.. (2024). Low-carbon upcycling of spent anode graphite: Integrating graphene and dislocations for sustainable lithium/potassium storage. Applied Surface Science. 679. 161262–161262. 5 indexed citations

Wu, Mingjun, Dan He, Yan Xiong, et al.. (2024). Multimodal smart systems reprogramme macrophages and remove urate to treat gouty arthritis. Nature Nanotechnology. 19(10). 1544–1557. 49 indexed citations breakdown →

Ge, Yang, Bo Zhang, Mingjun Wu, et al.. (2024). Improving Granulosa Cell Function in Premature Ovarian Failure with Umbilical Cord Mesenchymal Stromal Cell Exosome-Derived hsa_circ_0002021. Tissue Engineering and Regenerative Medicine. 21(6). 897–914. 8 indexed citations

Wu, Mingjun, et al.. (2023). Quality attributes for printable emulsion gels and 3D-printed tablets: Towards production of personalized dosage forms. International Journal of Pharmaceutics. 646. 123413–123413. 14 indexed citations

Chen, Ran, Mingjun Wu, Dezhang Zhao, et al.. (2023). M2 Macrophage Hybrid Membrane‐Camouflaged Targeted Biomimetic Nanosomes to Reprogram Inflammatory Microenvironment for Enhanced Enzyme‐Thermo‐Immunotherapy. Advanced Materials. 35(39). e2304123–e2304123. 68 indexed citations

Sang, Peng, Hongxiang Zeng, Yan Shi, et al.. (2021). α/Sulfono-γ-AApeptide Hybrid Analogues of Glucagon with Enhanced Stability and Prolonged In Vivo Activity. Journal of Medicinal Chemistry. 64(18). 13893–13901. 11 indexed citations

Wang, Tingting, Qunyou Tan, Dan He, et al.. (2021). Smart Stimuli-Responsive and Mitochondria Targeting Delivery in Cancer Therapy. International Journal of Nanomedicine. Volume 16. 4117–4146. 23 indexed citations

10.

He, Jin, Mingjun Wu, Lei Xiong, et al.. (2020). BTB/POZ zinc finger protein ZBTB16 inhibits breast cancer proliferation and metastasis through upregulating ZBTB28 and antagonizing BCL6/ZBTB27. Clinical Epigenetics. 12(1). 82–82. 42 indexed citations

11.

Feng, Yixiao, Mingjun Wu, Shuman Li, et al.. (2018). The epigenetically downregulated factor CYGB suppresses breast cancer through inhibition of glucose metabolism. Journal of Experimental & Clinical Cancer Research. 37(1). 313–313. 18 indexed citations

12.

YANG, Y, et al.. (2017). iTRAQ‐Based Proteomics of Chronic Renal Failure Rats after FuShengong Decoction Treatment Reveals Haptoglobin and Alpha‐1‐Antitrypsin as Potential Biomarkers. Evidence-based Complementary and Alternative Medicine. 2017(1). 1480514–1480514. 8 indexed citations

13.

Li, Ao, Xiaoxun Zhang, Shu Mao, et al.. (2017). Arctigenin suppresses renal interstitial fibrosis in a rat model of obstructive nephropathy. Phytomedicine. 30. 28–41. 49 indexed citations

14.

Yi, Xian, Mingjun Wu, Yaping Liu, et al.. (2017). Increased Sat2 expression is associated with busulfan-induced testicular Sertoli cell injury. Toxicology in Vitro. 43. 47–57. 4 indexed citations

15.

Xu, Ge, et al.. (2016). Mechanism of dihydroartemisinin-induced apoptosis in prostate cancer PC3 cells: An iTRAQ-based proteomic analysis. Life Sciences. 157. 1–11. 25 indexed citations

16.

Li, Ao, Jun Wang, Mingjun Wu, Xiaoxun Zhang, & Hongzhi Zhang. (2014). The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: Persistent p27Kip1 induction by interfering with PI3K/Akt/FOXO3a signaling pathway. European Journal of Pharmacology. 747. 71–87. 64 indexed citations

17.

He, Junlin, Mingjun Wu, Jiajia Li, et al.. (2014). iTRAQ-based proteomic analysis of tetramethylpyrazine inhibition on lipopolysaccharide-induced microglial activation. Life Sciences. 121. 46–56. 8 indexed citations

18.

Li, Jiang, Xiao Xiao, Jin Ren, et al.. (2014). Proteomic Analysis of Bladder Cancer Indicates Prx-I as a Key Molecule in BI-TK/GCV Treatment System. PLoS ONE. 9(6). e98764–e98764. 20 indexed citations

19.

Yu, Chao, et al.. (2013). A correlation between altered O-GlcNAcylation, migration and with changes in E-cadherin levels in ovarian cancer cells. Experimental Cell Research. 319(10). 1482–1490. 43 indexed citations

20.

Wang, Ranran, Chao Yu, Dezhang Zhao, Mingjun Wu, & Zhu Yang. (2013). The mucin-type glycosylating enzyme polypeptide N-acetylgalactosaminyltransferase 14 promotes the migration of ovarian cancer by modifying mucin 13. Oncology Reports. 30(2). 667–676. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact